April 23, 2021
Osaka-based Stella Pharma made its debut on the Tokyo Stock Exchange’s Mothers market on April 22, fetching a valuation of 23.7 billion yen. The company launched the world’s first boron neutron capture therapy (BNCT) last year, a new type of...read more